Comparison of inflammatory, nutrient, and neurohormonal indicators in patients with schizophrenia, bipolar disorder and major depressive disorder

被引:13
|
作者
Lyu, Nan [1 ,2 ,3 ]
Xing, Guoqiang [1 ,2 ,3 ]
Yang, Jian [1 ,2 ,3 ]
Zhu, Xuequan [1 ,2 ,3 ]
Zhao, Xixi [1 ,2 ,3 ]
Zhang, Ling [1 ,2 ,3 ]
Wang, Gang [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, 5 Ankang Hutong Rd, Beijing 100088, Peoples R China
[2] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China
关键词
Inflammation; Nutrition; Neurohormone; Schizophrenia; Major depressive disorder; Bipolar disorder; C-REACTIVE PROTEIN; HOMOCYSTEINE LEVELS; SERUM HOMOCYSTEINE; DNA METHYLATION; HPA AXIS; ASSOCIATION; SYMPTOMS; CORTISOL; BLOOD; ACID;
D O I
10.1016/j.jpsychires.2021.03.010
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Psychiatric disorders are severe, debilitating conditions with unknown etiology and are commonly misdiagnosed, when based solely on clinical interviews, because of overlapping symptoms and similar familial patterns. Until now, no valid and objective biomarkers have been used to diagnose and differentiate between psychiatric disorders. We compared clinically tested serum indicators in terms of inflammation (C-reactive protein, complement proteins C3 and C4, and serum Immunoglobulins A, M, and G), nutrients (homocysteine, folate, and vitamin B12), and neurohormones (adrenocorticotropic hormone and cortisol) in patients with schizophrenia (SCZ, n = 1659), bipolar disorder (BD, n = 1901), and major depressive disorder (MDD, n = 1521) to investigate potential biomarkers. A receiver operating characteristic (ROC) curve was used to analyze the diagnostic potential of these analytes. We found that compared with MDD, serum levels of C-reactive protein, C3, C4, and homocysteine were higher in SCZ and BD groups, and folate and vitamin B12 were lower in SCZ and BD groups. In contrast with BD, adrenocorticotropic hormone and cortisol increased in patients with MDD. Although ROC analysis suggested that they were not able to effectively distinguish between the three, these biological indicators showed different patterns in the three disorders. As such, more specific biomarkers should be explored in the future.
引用
收藏
页码:401 / 408
页数:8
相关论文
共 50 条
  • [1] A comparison of psychotic phenomena in bipolar disorder, major depressive disorder and schizophrenia
    Toh, W. L.
    Thomas, N.
    Rossell, S.
    BIPOLAR DISORDERS, 2016, 18 : 119 - 119
  • [2] Comparison of bipolar disorder with schizophrenia and major depressive disorder on affective temperaments and schizotypy
    Rybakowski, J.
    Dembinska-Krajewska, D.
    BIPOLAR DISORDERS, 2015, 17 : 76 - 76
  • [3] AMOTIVATION IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND MAJOR DEPRESSIVE DISORDER: A PRELIMINARY COMPARISON STUDY
    Zou, Ying-min
    Ni, Ke
    Wang, Yang-yu
    Yu, En-qing
    Lui, Simon S. Y.
    Cheung, Eric F. C.
    Chan, Raymond C. K.
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S129 - S129
  • [4] A transdiagnostic comparison of affective decision-making in patients with schizophrenia, major depressive disorder, or bipolar disorder
    Gu, Yu-ting
    Zhou, Chen
    Yang, Juan
    Zhang, Qin
    Zhu, Guo-hui
    Sun, Lin
    Ge, Mao-hong
    Wang, Yan-yu
    PSYCH JOURNAL, 2020, 9 (02) : 199 - 209
  • [5] Familial clustering of schizophrenia, bipolar disorder, and major depressive disorder
    Aukes, Maartje F.
    Laan, Wijnand
    Termorshuizen, Fabian
    Buizer-Voskamp, Jacobine E.
    Hennekam, Eric A. M.
    Smeets, Hugo M.
    Ophoff, Roel A.
    Boks, Marco P. M.
    Kahn, Rene S.
    GENETICS IN MEDICINE, 2012, 14 (03) : 338 - 341
  • [6] MITOCHONDRIAL VARIANTS IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND MAJOR DEPRESSIVE DISORDER
    Vawter, Marquis P.
    Rollins, B.
    Martin, M.
    Sequeira, A.
    Watson, S.
    Schatzberg, A.
    Akil, H.
    Myers, R.
    Jones, E.
    Wallace, D.
    Bunney, W.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 93 - 93
  • [7] Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
    Rollins, Brandi
    Martin, Maureen V.
    Sequeira, P. Adolfo
    Moon, Emily A.
    Morgan, Ling Z.
    Watson, Stanley J.
    Schatzberg, Alan
    Akil, Huda
    Myers, Richard M.
    Jones, Edward G.
    Wallace, Douglas C.
    Bunney, William E.
    Vawter, Marquis P.
    PLOS ONE, 2009, 4 (03):
  • [8] Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees
    Mitchell, Philip B.
    Frankland, Andrew
    Hadzi-Pavlovic, Dusan
    Roberts, Gloria
    Corry, Justine
    Wright, Adam
    Loo, Colleen K.
    Breakspear, Michael
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (04) : 303 - 309
  • [9] Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, And Major Depressive Disorder
    Carroll, Benjamin
    Ayyagari, Rajeev
    Thomason, Darren
    Mu, Fan
    Philbin, Michael
    NEUROLOGY, 2019, 92 (15)
  • [10] Retinal investigations in patients with major depressive disorder, bipolar disorder or schizophrenia: A review of the literature
    Tan, A.
    Schwitzer, T.
    Conart, J-B
    Angioi-Duprez, K.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2020, 43 (07): : 586 - 597